European Perspectives

Janine Collins, MBBS, LLM, Senior Director, European Risk Management - February 18, 2014
Last week, more than 100 senior Late Phase pharmaceutical professionals and key opinion leaders representing Medical and Scientific Affairs, Health Economics and Outcomes Research, Safety and Risk Management, Regulatory, Market Access...
A UBC study assesses health-related quality of life of multiple myeloma patients
UBC - February 14, 2014
A study, designed and undertaken by medical and industry experts including Krista Payne and Noreen Lordan of UBC, assesses the health-related quality of life (HRQoL) of 154 patients with multiple myeloma (MM).  This cross-...
UBC - February 06, 2014
The convergence of payer and regulator evidence requirements warrants a strategic evidence generation plan and a mindful orchestration of peri and postapproval real-world studies.  Study designs resulting in a diverse array of...
Janine Collins, MBBS, LLM, Senior Director, European Risk Management - January 24, 2014
This week, I had the privilege of chairing the 4th Annual Pharmacovigilance & Risk Management Strategies Conference in Amsterdam, Netherlands.  This event struck me as unique because the conversations were not theoretical; we...
UBC provides expertise on pre- and postapproval risk management strategies
UBC - January 21, 2014
Once a medical product is taken out of a highly controlled clinical environment and is made available through physicians to their patients, additional risks and unknown safety issues may become apparent. Therefore, proactive risk...

Pages